发明名称 USE OF B-TYPE BOTULINUS TOXIN FOLLOWED BY A-TYPE BOTULINUS TOXIN FOR TREATING DYSTONIA
摘要 <P>PROBLEM TO BE SOLVED: To provide a method for obtaining a treatment effect even after clinical response for administration of an A-type botulinus toxin has decreased in treatment of neuromuscular disease. Ž<P>SOLUTION: An effective treatment amount of the A-type botulinus toxin is administrated until a patient experiences a decrease in clinical response for its administration, and thereafter an effective treatment amount of a B-type botulinus toxin is administrated to the patient so that neuromuscular disease is treated. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
申请公布号 JP2010111703(A) 申请公布日期 2010.05.20
申请号 JP20100013371 申请日期 2010.01.25
申请人 ALLERGAN INC 发明人 AOKI K ROGER;GRAYSTON MICHAEL W;CARLSON STEVEN R;LEON JUDITH M
分类号 A61K38/00;A61K35/74;A61K38/16;A61K38/48;A61P21/00;A61P21/02;A61P25/00;A61P25/02;A61P43/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址